CODX

NASDAQ 已收盘

Co-Diagnostics, Inc.

1.51 USD
+0.04+2.03%
盘后 1.50 +1.35%
2026-08-03
市值
$7.97M
市盈率
EPS
-29.82
股息率
52 周区间
1.26 – 46.50
成交量
450.19K
Beta
2.85
目标价
52W 低 1.2652W 高 46.50
价格走势

公司简介

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In...